Atropine Eye Drops for Myopia: What Oakville Parents Need to Know in 2026
Dr. Tina Goodhew
June 2, 2026
If your child’s prescription seems to climb every time you come in for an exam, you are probably wondering what can actually be done about it. Atropine eye drops are one of the most studied interventions in myopia management today, and the evidence behind them has grown considerably in recent years. This guide covers how they work, what the current research says about dosing, how atropine fits into combination treatment plans, and what your family can expect if you decide to move forward.
How Low-Dose Atropine Eye Drops Slow Myopia Progression
Myopia develops when the eyeball grows too long from front to back. Light focuses just short of the retina instead of landing directly on it, which is what causes blurry distance vision. The concern is not just the prescription itself. The longer the eye grows, the higher the risk of serious complications later in life, including retinal detachment, glaucoma, and macular degeneration.
Atropine has been used in eye care for well over a century. At the low concentrations used for myopia management (0.01% to 0.05%), it does something distinct from the higher-dose drops used to dilate pupils during an exam, which are 20X stronger! Rather than primarily affecting the muscles that control focus, low-dose atropine is thought to act on receptors in the retina and sclera (the white outer coating of the eye) that influence how quickly the eye grows. The exact mechanism is still being studied, but the clinical evidence for its effect on slowing axial elongation is well established across multiple large trials.
How it Works
Low-dose atropine eye drops targets muscarinic receptors in the eye’s deeper tissues, slowing the growth signals that cause the eyeball to lengthen. It works through a different biological pathway than glasses or contact lenses.
What the Studies Show
Major clinical trials including ATOM2 and the LAMP series have found that low-dose atropine can reduce myopia progression by 40 to 70% compared to no treatment, depending on concentration and the child’s age when they became myopic.
Who Benefits Most
Children with fast-progressing prescriptions, early onset (before age 8), or a strong family history of myopia tend to see the most meaningful benefit. Starting earlier generally produces better long-term outcomes.
The Atropine Concentration Debate: 0.01% vs. 0.05% and Beyond
For most of the past decade, 0.01% atropine was the standard recommendation. The ATOM2 study, published in 2012, showed it carried far fewer side effects than higher concentrations, with minimal impact on near vision or light sensitivity. That made it easy to prescribe and easy for children to tolerate.
The LAMP study changed the picture. Over multiple years, it compared 0.01%, 0.025%, and 0.05% atropine eye drops in children ages 4 to 12 and found a clear dose-dependent effect: 0.05% consistently produced the greatest reduction in axial elongation, with 0.025% in between. The eight-year follow-up data, now extending into 2025, has reinforced those findings.
One of the questions the myopia management community is working through in 2026 is whether 0.01% atropine is still effective enough as a standalone treatment for most children, or whether the evidence now favors starting at a higher concentration. There is no single answer. The right concentration depends on how quickly your child’s myopia is progressing, how old they were when it started, and what other treatments are being considered.
“The question is no longer whether atropine works. It is which concentration, for which child, and whether it should be paired with other treatments to get the best possible result.”
Atropine works through a biochemical pathway inside the eye. Optical treatments like orthokeratology (ortho-k lenses worn overnight to reshape the cornea), MiSight daily contact lenses, and Stellest spectacle lenses work through a different mechanism: they adjust how light lands on the peripheral retina in a way that reduces the signal driving eye growth. Because these are genuinely separate pathways, combining them is a logical next step.
The research on combination therapy is still building, but the early results are encouraging. Children using ortho-k alongside low-dose atropine have consistently shown slower axial elongation than those using either treatment alone. Studies pairing atropine with MiSight and Stellest are ongoing, and the preliminary data suggests a meaningful additive effect. That does not mean every myopic child needs combination therapy. For many families, a single well-chosen treatment is a perfectly reasonable starting point. But for children with rapid progression, early onset, or high parental myopia, a combined approach is worth discussing.
At Abbey Eye Care, we look at each child as an individual. We review rate of change, age of onset, and family history before recommending a plan, and we revisit that plan regularly as the child grows. Our goal is to give you the best available tools, applied in a way that makes sense for your child specifically.
What to Expect When Your Child Starts Atropine Drops
A new treatment always comes with questions. Below is what the day-to-day experience looks like for most families starting low-dose atropine.
- Timing: Drops are applied once daily, most often at bedtime. This keeps any effect on near vision or light sensitivity well away from school hours and activities.
- Side effects: At 0.01% to 0.05%, side effects are generally minimal. A small number of children notice mild light sensitivity or a slight reduction in near-focus sharpness early in treatment. These typically settle within a few weeks as the eyes adjust.
- Availability: Low-dose atropine is not stocked at standard pharmacies in Canada. It is prepared by a compounding pharmacy. We will coordinate that referral for you as part of initiating the prescription.
- Follow-up schedule: We see children on atropine every six months, measuring axial length and prescription at each visit. This lets us confirm the treatment is working and adjust the plan if it is not.
- Duration: Atropine is a long-term commitment. Most children continue through their mid-to-late teens, when eye growth naturally slows. Stopping early, especially at higher concentrations, can trigger a rebound period of faster progression. We manage the tapering process carefully when the time comes.
- Glasses and contacts still apply: Atropine does not replace your child’s optical correction. It works alongside glasses or contact lenses to slow how quickly the prescription changes.
Most families find the routine easy to maintain. One drop at night before bed. The bigger shift is thinking about myopia management as an ongoing relationship rather than a one-time decision, and that is exactly what we are here for.
FAQ’s
Are there side effects from low-dose atropine drops?
At the concentrations used in myopia management (0.01% to 0.05%), side effects tend to be mild. Some children notice a small amount of light sensitivity or a subtle reduction in near focus, particularly in the first few weeks. These effects are far less pronounced than with the higher concentrations used during a dilated eye exam. If your child finds symptoms bothersome, there are ways to adjust.
How long does my child need to use atropine?
Atropine is typically continued through the years when the eyes are still actively growing, often into the mid-to-late teens. Stopping abruptly, particularly at higher concentrations, can lead to a rebound effect where progression picks up. We handle the tapering process as part of ongoing care, so there is a clear plan for eventually stopping when the time is right.
Can atropine permanently stop myopia from getting worse?
Atropine significantly slows the rate of progression, but it does not freeze it entirely. The goal is to reduce the total amount of myopia your child develops over time, keeping the prescription lower and reducing their lifetime risk for myopia-related eye disease. In some children the effect is substantial; in others it is more modest. Tracking at each visit means you always know how the treatment is performing.
Do we need a referral to discuss atropine for our child?
No referral is needed. If you are concerned about your child’s prescription or want to understand your options before the next exam, you can book a myopia consultation directly with us. We will review your child’s history, measure their eye length, and walk through the treatment options that make sense for them.
BOOK YOUR CHILD’S EYE EXAM
Wondering whether your child’s vision has changed, or whether they might benefit from a myopia management plan? Our team at Abbey Eye Care in Oakville stays at the forefront of pediatric eye care and myopia management, and we’d love to help your family see the bigger picture. Book an eye exam today and let’s make sure their eyes are growing in the right direction.
OUR MYOPIA CLINIC
Worried about your child’s prescription climbing year after year? Our dedicated Myopia Clinic
offers proven management options which include: Spectacle lenses, Ortho-K, specialty soft contact lenses, and atropine therapy, all designed to slow myopia progression and protect the long-term eye health of you child.
